Log in
Enquire now
‌

US Patent 10344262 Differentiation of primate pluripotent stem cells to hematopoietic lineage cells

Patent 10344262 was granted and assigned to Asterias Biotherapeutics on July, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Asterias Biotherapeutics
Asterias Biotherapeutics
Current Assignee
Asterias Biotherapeutics
Asterias Biotherapeutics
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10344262
Date of Patent
July 9, 2019
Patent Application Number
15426030
Date Filed
February 6, 2017
Patent Primary Examiner
‌
Scott Long
Patent abstract

The invention provides methods of differentiating primate pluripotent stem cells into cells of hematopoietic lineage. The invention further provides hematopoietic lineage cells differentiated from primate pluripotent stem cells, as well as methods of using the same and kits comprising the same.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10344262 Differentiation of primate pluripotent stem cells to hematopoietic lineage cells

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.